bpc-157 trials BPC-157: Miracle Healing Peptide or Hidden Danger? bpc-157 clinical trials dosage humans
Description
It's pretty fun. When the team tested their high scoring computationally designed enzyme in the lab, they found that it was 116 times more active and 877 times more specific for the immunogenic gluten-derived peptide relative to wild type kumamolisin-As (6)
What Affects BAC
BPC 157 counteracted increased P wave amplitude, tachycardia and ST-elevation, i.e ., right heart failure from acute thrombotic coronary occlusion
Individuals with Raynauds disease experience exaggerated vascular responses to cold that can cause tissue damage and should avoid cold therapy
Document patients pain before, during, and after injection
